BioLineRx Ltd.
BLRX · NASDAQ
11/24/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$3,940 | $5,127 | -$3,187 |
| Dep. & Amort. | – | $176 | $165 | $1,852 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $53 | $194 | -$154 |
| Change in WC | – | $1,870 | -$513 | -$410 |
| Other Non-Cash | – | $1,664 | -$7,564 | -$6,711 |
| Operating Cash Flow | – | -$177 | -$2,591 | -$8,610 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | $11 | $0 | $6 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | -$12,511 | -$12,307 | $0 |
| Inv. Sales/Matur. | – | $8,796 | $4,130 | $11,152 |
| Other Inv. Act. | – | $0 | $0 | -$1 |
| Investing Cash Flow | – | -$3,704 | -$8,177 | $11,157 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | -$1,255 | -$1,247 | -$12,103 |
| Stock Issued | – | $2,857 | $10,697 | $10,999 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $0 | $0 | -$5 |
| Financing Cash Flow | – | $1,602 | $9,450 | -$1,109 |
| Forex Effect | – | $432 | -$82 | $162 |
| Net Chg. in Cash | – | -$1,847 | -$1,400 | $1,600 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $9,036 | $10,436 | $8,836 |
| End Cash | – | $7,189 | $9,036 | $10,436 |
| Free Cash Flow | – | -$177 | -$2,591 | -$8,605 |